176 related articles for article (PubMed ID: 33959953)
1. Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
Xu R; Huang X; Li C; Deng C; Li M; Wu P; Geng S; Lai P; Lu Z; Weng J; Du X
Br J Haematol; 2021 Jun; 193(5):928-940. PubMed ID: 33959953
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
Wu L; Amarachintha S; Xu J; Oley F; Du W
Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
[TBL] [Abstract][Full Text] [Related]
3. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
[TBL] [Abstract][Full Text] [Related]
4. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ
Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124
[TBL] [Abstract][Full Text] [Related]
5. Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.
Pavlaki K; Pontikoglou CG; Demetriadou A; Batsali AK; Damianaki A; Simantirakis E; Kontakis M; Galanopoulos A; Kotsianidis I; Kastrinaki MC; Papadaki HA
Stem Cells Dev; 2014 Jul; 23(14):1568-81. PubMed ID: 24617415
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
[TBL] [Abstract][Full Text] [Related]
7. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.
Yoshimi A; Balasis ME; Vedder A; Feldman K; Ma Y; Zhang H; Lee SC; Letson C; Niyongere S; Lu SX; Ball M; Taylor J; Zhang Q; Zhao Y; Youssef S; Chung YR; Zhang XJ; Durham BH; Yang W; List AF; Loh ML; Klimek V; Berger MF; Stieglitz E; Padron E; Abdel-Wahab O
Blood; 2017 Jul; 130(4):397-407. PubMed ID: 28576879
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.
Zhang B; Li M; McDonald T; Holyoake TL; Moon RT; Campana D; Shultz L; Bhatia R
Blood; 2013 Mar; 121(10):1824-38. PubMed ID: 23299311
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor can signal via β-catenin to control proliferation of mesenchymal stem cells independently of canonical Wnt signalling.
Knight C; James S; Kuntin D; Fox J; Newling K; Hollings S; Pennock R; Genever P
Cell Signal; 2019 Jan; 53():256-268. PubMed ID: 30287279
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
[TBL] [Abstract][Full Text] [Related]
11. Erratum to: Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: Overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
Br J Haematol; 2023 May; 201(4):797. PubMed ID: 36929153
[No Abstract] [Full Text] [Related]
12. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury.
Wang C; Zhu H; Sun Z; Xiang Z; Ge Y; Ni C; Luo Z; Qian W; Han X
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C234-44. PubMed ID: 24898581
[TBL] [Abstract][Full Text] [Related]
13. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia.
Mangolini M; Götte F; Moore A; Ammon T; Oelsner M; Lutzny-Geier G; Klein-Hitpass L; Williamson JC; Lehner PJ; Dürig J; Möllmann M; Rásó-Barnett L; Hughes K; Santoro A; Méndez-Ferrer S; Oostendorp RAJ; Zimber-Strobl U; Peschel C; Hodson DJ; Schmidt-Supprian M; Ringshausen I
Nat Commun; 2018 Sep; 9(1):3839. PubMed ID: 30242258
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
Michaux JL; Martiat P
Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM; Lasho T
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
17. Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.
Hussein K; Büsche G; Muth M; Göhring G; Kreipe H; Bock O
Ann Hematol; 2011 Mar; 90(3):307-13. PubMed ID: 20842500
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signaling mediates the abnormal osteogenic and adipogenic capabilities of bone marrow mesenchymal stem cells from chronic graft-versus-host disease patients.
Qi HZ; Ye YL; Suo Y; Qu H; Zhang HY; Yang KB; Fan ZP; Huang F; Xuan L; Chen YQ; Jin H; Liu QF
Cell Death Dis; 2021 Mar; 12(4):308. PubMed ID: 33758171
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stem cells could acquire the phenotypes of epithelial cells and accelerate vaginal reconstruction combined with small intestinal submucosa.
Li Y; Liu F; Zhang Z; Zhang M; Cao S; Li Y; Zhang L; Huang X; Xu Y
Cell Biol Int; 2015 Nov; 39(11):1225-33. PubMed ID: 26018040
[TBL] [Abstract][Full Text] [Related]
20. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway.
Rong X; Liu J; Yao X; Jiang T; Wang Y; Xie F
Stem Cell Res Ther; 2019 Mar; 10(1):98. PubMed ID: 30885249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]